Novartis, Eli Lilly and AbbVie join growing list of Big Pharmas severing ties with Russia
After watching the ongoing chaos of Russia’s invasion of Ukraine, a growing lineup of the world’s biggest pharma giants are taking their next, closely watched steps amid a global backlash — pulling out of Russia for a full slate of business activities and, for some, handing over profits on anything that remains.
The latest moves come after criticism of pharma for failing to stop doing business in Russia — while many of the world’s businesses have been pulling a hasty retreat out of Russia as bombs fall in Ukraine.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters